Patent · US Active

Anti-complement factor C1q antibodies and uses thereof

US10590190B2 · kind B2 · utility

5Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 2019
Grant dateMar 17, 2020
Priority date—
Expiry dateJan 4, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4716
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides anti-C1q antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.